NCT07661836 Personalized Online Occupational Therapy Intervention for Adults With Scleroderma Status ACTIVE_NOT_RECRUITING Phase NA
NCT07641634 A Phase 1/2 Study of PRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis. Status RECRUITING Phase PHASE1/PHASE2
NCT06991114 AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases. Status RECRUITING Phase PHASE2
NCT06843239 Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06801119 Efficacy and Safety of HN2301 in Autoimmune Diseases(AIDs) Status RECRUITING Phase PHASE1
NCT06328777 RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis Status RECRUITING Phase PHASE2/PHASE3
NCT05925803 Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05098704 Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk Status RECRUITING Phase PHASE2/PHASE3